Literature DB >> 22112579

Exploring the binding mechanism of ondansetron hydrochloride to serum albumins: spectroscopic approach.

Sandhya B1, Ashwini H Hegde, Ramesh K C, Seetharamappa J.   

Abstract

The mechanism of interaction of ondansetron hydrochloride (OND) to serum albumins [bovine serum albumin (BSA) and human serum albumin (HSA)] was studied for the first time employing fluorimetric, circular dichroism, FTIR and UV-vis absorption techniques under the simulated physiological conditions. Fluorimetric results were utilized to investigate the binding and conformational characteristics of protein upon interaction with varying concentrations of the drug. Higher binding constant values revealed the strong interaction between the drug and protein while the number of binding sites close to unity indicated single class of binding site for OND in protein. Thermodynamic results revealed that both hydrogen bond and hydrophobic interactions played a major role in stabilizing drug-protein complex. Site marker competitive experiments indicated that the OND bound to albumins at subdomin II A (Sudlow's site I). Further, the binding distance between OND and serum albumin was calculated based on the Förster's theory of non-radioactive energy transfer and found to be 2.30 and 3.41 nm, respectively for OND-BSA and OND-HSA. The circular dichroism data revealed that the presence of OND decreased the α-helix content of serum albumins. 3D-fluorescence results also indicated the conformational changes in protein upon interaction with OND. Further, the effects of some cations have been investigated in the interaction of drug to protein.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112579     DOI: 10.1016/j.saa.2011.10.060

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  4 in total

1.  PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics.

Authors:  Rachel Huddart; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-06       Impact factor: 2.089

2.  Spectroscopic analysis of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-6-methylquinolin-4-ol binding to blood plasma albumin.

Authors:  Karine R Grigoryan; Hasmik A Shilajyan; Ashkhen Zatikyan; Iskuhi Aleksanyan; Lilit Hambardzumyan
Journal:  Monatsh Chem       Date:  2022-05-09       Impact factor: 1.613

3.  Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator.

Authors:  Udoamaka Ezuruike; Mian Zhang; Amita Pansari; Mailys De Sousa Mendes; Xian Pan; Sibylle Neuhoff; Iain Gardner
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-04-18

4.  Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis.

Authors:  Anna Vassall; Sudhashree Chandrashekar; Michael Pickles; Tara S Beattie; Govindraj Shetty; Parinita Bhattacharjee; Marie-Claude Boily; Peter Vickerman; Janet Bradley; Michel Alary; Stephen Moses; Charlotte Watts
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.